Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.48%, DAX +0.61%, CAC40 +0.31%

Jul 31 ,2026

  • Synopsis

    • European indicies are set to open higher with Asian equities rallying Friday.

    • Memory rally the big market story with SK Hynix (000660.KS) and Samsung Electronics (005930.KS) rebounding more than 20%. Taiwan and Hong Kong-listed semis also sharply higher. Nothing specific behind the bounce, which follows heavy recent drawdown attributed to factors including unwinding of leveraged positions,

    • BOJ left interest rates unchanged as expected in an 8-1 vote. Reaffirmed intent to continue raising interest rates with underlying inflation approaching 2% and financial conditions accommodative

    • US equities were higher in Thursday trading as stocks ended no far off best levels. However, equal-weight S&P (RSP) lagged by over 180 bp after six straight days of outperformance

    • Friday sees, in central banks, Swiss National Bank reporting H1 earnings

    • Economic: Germany Jul unemployment rate, France Jul preliminary CPI, Jun PPI, Italy Jul preliminary CPI, business/consumer confidence, Eurozone Jul flash CPI, UK Jul house price index - Nationwide, Switzerland Jun retail sales, Netherlands Jul preliminary CPI, Finland Jul preliminary HICP, Austria Jul preliminary CPI, Portugal Jul preliminary CPI, Greece May retail sales

    • Earnigs reported so far: UMI.BB, SUR.GR, BRNL.NA, LDO.IM, WDP.BB, ACA.FP, UNI.SM, FUR.NA, CS.FP, FPE3.GR, HOLN.SW.

  • Politics/Macro/World News

    • Spain's migrant crisis triggers Italian call for EU travel restrictions (FT )

  • Top company news

    • Earnings/updates

      • UMG.NA (Universal Music Group) -- reports Q2 Adj. EBITDA €674M vs consensus €710M

      • SHL.GR (Siemens Healthineers) -- reports Q3 adjusted EPS €0.70 vs consensus €0.53

      • HOLN.SW (Holcim) -- reports Q2 recurring EBIT CHF1.01B vs consensus CHF958.0M; guides FY net sales, recurring EBIT to high end of targets

      • SGO.FP (Compagnie de Saint-Gobain) -- reports H1 Recurring net income €1.68B vs FactSet €1.54B [1 est]; confirms FY guidance

      • ENEL.IM (Enel) -- reports H1 net income €3.74B vs FactSet €3.74B [3 est, €3.69-3.78B]

      • CLNX.SM (Cellnex Telecom) -- reports H1 adjusted EBITDA €1.69B vs FactSet €1.66B [1 est]

      • BC.IM (Brunello Cucinelli) -- reports H1 net income €76.1M vs FactSet €74.1M [6 est, €72-77M]; raises FY Revenue growth guidance to +10-11% vs prior +10%

      • TEP.FP (Teleperformance) -- reports H1 EBITA €662M ex-items vs FactSet €647.0M; reaffirms 2026 financial targets

      • ENX.FP (Euronext) -- reports Q2 EPS €2.42 vs FactSet €2.20 [6 est, €2.01-2.31]

      • AMP.IM (Amplifon) -- reports Q2 Adj. EPS €0.24 vs FactSet €0.22 [6 est, €0.19-0.24]

      • WLN.FP (Worldline) -- reports H1 adj net income attributable €65M vs FactSet €62M

      • FRVIA.FP (Forvia) -- reports H1 operating income €632M vs consensus €592.8M; FY26 guidance confirmed

      • CLN.SW (Clariant) -- reports Q2 adjusted EBITDA CHF171.1M vs consensus CHF149M; confirms FY guidance

      • ETE.GA (National Bank of Greece) -- Follow-up: National Bank of Greece guides FY EPS > €1.40 vs prior ~ €1.40 and FactSet €1.41 [18 est, €1.29-1.50]

      • ANA.SM (Acciona) -- reports H1 net income attributable €83M vs FactSet €83.7M [3 est, €67-96M]; reaffirms FY guidance

      • HAG.GR (HENSOLDT) -- reports H1 adjusted EBITDA €137M, +28% vs year-ago €107M

      • VIRI.FP (Viridien) -- reports Q2 net income ($26M) vs FactSet ($6.5M) [2 est, ($13)-0M]

      • IGG.LN (IG Group Holdings) -- reports H1 EPS 68.9p ex-items vs FactSet 61.2p [2 est, 56.2-66.3p]

      • EUROB.GA (Eurobank SA) -- Follow-up: Eurobank expects 2026 EPS growth well above +10%

      • PUIG.SM (Puig Brands) -- reports H1 net income attributable €262.8M vs FactSet €257.8M [4 est, €250-265M]; reaffirms FY outlook

      • MOVE.SW (Medacta Group) -- reports prelim. H1 revenue €368M vs FactSet €372.0M [2 est, €367.7-376.2M]; Reaffirms FY and mid-term outlook

      • VU.FP (VusionGroup) -- reports H1 revenue €839M, +29% vs year-ago €649.3M

      • HLE.GR (FORVIA HELLA) -- reports H1 revenue €4.04B, +2% vs year-ago €3.98B

      • MEL.SM (Melia Hotels International) -- reports Q2 net income attributable (€7.6M) including impairments (post EU close 30-Jul)

      • COTN.SW (COMET Holding) -- reports H1 net income CHF13.5M vs FactSet CHF7.5M [2 est, CHF1.4-13.6M]

      • LSS.FP (Lectra) -- reports Q2 net income €9.2M vs FactSet €5.6M [1 est]

      • POXEL.FP (Poxel) -- reports Q2 revenue €1.2M vs year-ago €1.0M

      • RENE.PL (Redes Energeticas Nacionais SGPS) -- reports H1 net income €93.4M vs FactSet €94M [1 est]

      • VANTI.FP (Vantiva) -- reports H1 net income (€68M) vs year-ago (€295M)

      • XFAB.FP (X-FAB Silicon Foundries) -- reports Q2 EPS ($0.11) vs FactSet ($0.04) [2 est, ($0.06)-(0.02)]

      • INRN.SW (Interroll Holding) -- reports H1 net income CHF19.8M vs FactSet CHF24.7M [3 est, CHF18.9-33.9M]

      • COFA.FP (Coface) -- reports H1 net income €107.8M vs FactSet €109M [1 est]

      • CLTN.SW (Coltene Holding) -- reports H1 net income CHF4.1M vs year-ago CHF4.3M

      • MTU.FP (Manitou BF) -- reports H1 net income €51M, +55% vs year-ago €33M; raises FY Revenue growth guidance to +6.5-8.0% vs prior +5%

      • EXAE.GA (Hellenic Exchanges-Athens Stock Exchange) -- Euronext Athens reports H1 net income €27.0M vs year-ago €13.5M

      • CAF.SM (Construcciones y Auxiliar de Ferrocarriles) -- reports H1 net income attributable €99M vs FactSet €86.1M [2 est, €84.8-87.4M]; reaffirms its 2026 outlook

      • NCH2.GR (thyssenkrupp nucera) -- reports preliminary Q3 EBIT (€2M) vs FactSet (€8.8M) [1 est]

    • M&A

      • HSBA.LN (HSBC Holdings) -- sells Australian home loan and personal loan portfolio to Blackstone affiliate Virgo BidCo for A$36B ($25B)

      • ORA.FP (Orange) -- France explores sale of partial stake in telecom operator Orange S.A. in a deal that could be valued at ~ €1.1B - Reuters

      • IGG.LN (IG Group Holdings) -- plc discloses the proposed acquisition of Underdog for total consideration of up to ~$1.3B

      • IGG.LN (IG Group Holdings) -- Transcript Intelligence: IG Group Holdings Acquisition of Underdog Sports Holdings, Inc. plc Call

      • BSBR (Banco Santander (Brasil)) -- Banco Santander offers to acquire outstanding shares of Santander Brazil, maximum consideration of €1.91B at a premium of 15%

      • ZAB.PW (Zabka Group) -- Alimentation Couche-Tard to acquire Zabka Group for PLN32/share, or total equity value of PLN32.62B ($8.6B)

      • (OTHER) ICAD.FP (Icade) -- announces the acquisition of a controlling interest in Comet, a leader in the corporate events industry. Terms were not disclosed

      • (OTHER) ASA.NO (Atlantic Sapphire) -- Coral HoldCo launches recommended mandatory tender offer for Atlantic Sapphire at NOK0.80/share

      • (OTHER) AX1.AU (Accent Group) -- Takeovers Panel declines to conduct proceedings in relation to Frasers Group's application regarding Accent Group

      • (OTHER) AMP.SM (Amper) -- acquires the productive business unit of Freqcon GmbH for €1.7M

      • (OTHER) MGH.AU (MAAS Group) -- ACCC approves Heidelberg's acquisition of Maas's construction materials business

      • (OTHER) AKBM.NO (Aker BioMarine) -- Aker Capital announces result of optional cash offer for Aker BioMarine

      • (OTHER) CVW.AU (ClearView Wealth) -- Zurich's scheme to acquire ClearView Wealth now effective

    • Healthcare

      • AZN.LN (AstraZeneca) -- AstraZeneca's Efzimfotase alfa (ALXN1850) injection (subcutaneous) to be included for priority review by China's NMPA in hypophosphatasia (HPP)

      • ANAB (AnaptysBio) -- discloses stipulation proposing schedule governing post-trial briefing in connection with TESARO litigation - 8-K

      • ABVX.FP (Abivax) -- announces completion of its pre-NDA interaction with the FDA for obefazimod

      • DBV.FP (DBV Technologies) -- announces sale of ~$50M of ADSs through ATM program

      • FRE.GR (Fresenius) -- FDA approves Fresenius Kabi's NDA for Glycophos in adults and children 12 and older

    • Other

      • CLNX.SM (Cellnex Telecom) -- plans to cancel 18.3M own shares

      • ALPHA.GA (Alpha Bank SA) -- Alpha Bank appoints I. Kiouroukoglou as Chief of Wholesale Banking with effect as of 15-Sep

      • WBD.IM (Webuild) -- awarded €803M contract for Genoa undersea road tunnel

      • Allreal Holding receives building permit for sustainable residential property on Badenerstrasse in Zurich

  • Key rating changes

    • Downgrades

      • GRG.LN (Greggs) -- to sector perform from outperform at RBC Capital Markets

    • Other Actions

      • HEXA.B.SS (Hexagon) -- reinstated neutral at Goldman Sachs

  • Data

    • Nikkei +4.33% to 64547.63

    • Hang Seng (0.27%) to 25788.51

    • Shanghai Composite +0.84% to 3836.64

    • S&P futures +36.8 vs prior close of 7472.5

    • €-$ (0.0021) or (0.18%) to 1.1507

    • $-¥ +1.22 or +0.77% to 160.72

    • €-¥ +1.05 or +0.57% to 184.92

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.